Stable Isotope Labeled Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade

Reference: PX-TA1365-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Description of Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade

General information on Anti-CD19[Homo sapiens] (Tafasitamab) Monoclonal Antibody

Tafasitamab is a humanized monoclonal antibody that targets CD19. It is used for the treatment of B-cell malignancies. The CD19 surface protein is highly expressed on the surface of B-cells where it enhances B-cell receptor signaling. CD19 is especially expressed in cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL). By its activity, tafasatimab induces the lysis of B-cells.

Product nameStable Isotope Labeled Tafasitamab Biosimilar - Anti-CD19 mAb - Research Grade
SourceCAS 1422527-84-1
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsMOR-00208,MOR-208,XENP-5574,XMP-5574,XmAb-5574,Xmab-CD19
ReferencePX-TA1365-SIL
Related ProductsPX-P4004
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-G2-kappa
ClonalityMonoclonal Antibody
SourceCAS 1422527-84-1
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2
Isotopic Enrichment99%
Stability1 year

Reviews

There are no reviews yet.

Be the first to review “Stable Isotope Labeled Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade”

Your email address will not be published.


1,500.00

OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: